nach oben

NeuroMolecular Medicine

Erschienen in:

01.12.2009 | Review Paper

From Manganism to Manganese-Induced Parkinsonism: A Conceptual Model Based on the Evolution of Exposure

verfasst von: Roberto G. Lucchini, Christopher J. Martin, Brent C. Doney

Erschienen in: NeuroMolecular Medicine | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

Manganism is a distinct medical condition from Parkinson’s disease. Manganese exposure scenarios in the last century generally have changed from the acute, high-level exposure conditions responsible for the occurrence of manganism to chronic exposure to much lower levels. Such chronic exposures may progressively extend the site of manganese deposition and toxicity from the globus pallidus to the entire area of the basal ganglia, including the substantia nigra pars compacta involved in Parkinson’s disease. The mechanisms of manganese neurotoxicity from chronic exposure to very low levels are not well understood, but promising information is based on the concept of susceptibility that may place individuals exposed to manganese at a higher risk for developing Parkinsonian disturbances. These conditions include mutations of genes which play important pathogenetic roles in both Parkinsonism and in the regulation of manganese transport and metabolism. Liver function is also important in manganese-related neurotoxicity and sub-clinical impairment may increase the risk of Parkinsonism. The purpose and scope of this report are to explore the literature concerning manganese exposure and potential subclinical effects and biological pathways, impairment, and development of diseases such as Parkinsonism and manganism. Inhalation and ingestion of manganese will be the focus of this report.

ACGIH^®. (2009). TLVs^® and BEIs^®, ACGIH^®. Cincinnati, OH.

Agarwal, G. S., Sharma, R., & Bhatnagar, V. (2008). Assessment of latent manganese toxicity as a prognostic factor following surgery for biliary atresia. European Journal of Pediatric Surgery, 18(1), 22–25.CrossRefPubMed

Alves, G., Müller, B., Herlofson, K., Hogenesch, I., Telstad, W., Aarsland, D., et al. (2009). Incidence of Parkinson’s disease in Norway. The Norwegian ParkWest study. Journal of Neurology, Neurosurgery, and Psychiatry [Epub ahead of print].

Anderson, J. G., Cooney, P. T., & Erikson, K. M. (2007). Inhibition of DAT function attenuates manganese accumulation in the globus pallidus. Environmental Toxicology and Pharmacology, 23(2), 179–184.CrossRefPubMed

Antunes, M. B., Bowler, R., & Doty, R. L. (2007). San Francisco/Oakland Bay Bridge Welder Study: Olfactory function. Neurology, 69(12), 1278–1284.CrossRefPubMed

Aschner, J. L., & Aschner, M. (2005). Nutritional aspects of manganese homeostasis. Molecular Aspects of Medicine, 26(4–5), 353–362.CrossRefPubMed

Bouchard, M., Laforest, F., Vandelac, L., Bellinger, D., & Mergler, D. (2007). Hair manganese and hyperactive behaviors: Pilot study of school-age children exposed through tap water. Environmental Health Perspectives, 115, 122–127.PubMed

Calne, D. B., Chu, N. S., Huang, C. C., Lu, C. S., & Olanow, W. (1994). Manganism and idiopathic Parkinsonism: Similarities and differences. Neurology, 44(9), 1583–1586.PubMed

Canossa, E., Angiuli, G., Garasto, G., Buzzoni, A., & De Rosa, E. (1993). Dosage indicators in farm workers exposed to mancozeb. La Medicina del lavoro, 84(1), 42–50.PubMed

Cory-Slechta, D. A. (2005). Studying toxicants as single chemicals: Does this strategy adequately identify neurotoxic risk? Neurotoxicology, 26(4), 491–510.CrossRefPubMed

Costello, S., Cockburn, M., Bronstein, J., Zhang, X., & Ritz, B. (2009). Parkinson’s disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. American Journal of Epidemiology, 169(8), 919–926.CrossRefPubMed

Cotzias, G. C. (1958). Manganese in health and disease. Physiological Reviews, 38, 503–532.PubMed

Couper, J. (1837). On the effects of black oxide of manganese when inhaled into the lungs. British Annals of Medicine and Pharmacology, 1, 41–42.

Cowan, D. M., Fan, Q., Zou, Y., Shi, X., Chen, J., Aschner, M., et al. (2009). Manganese exposure among smelting workers: Blood manganese-iron ratio as a novel tool for manganese exposure assessment. Biomarkers, 14(1), 3–16.CrossRefPubMed

Curran, C. P., Park, R. M., Ho, S.-m., & Haynes, E. N. (2008). Incorporating genetics and genomics in risk assessment for inhaled manganese: From data to policy. Neurotoxicology, 30(5), 754–760.CrossRef

da Silva, C. J., da Rocha, A. J., Jeronymo, S., Mendes, M. F., Milani, F. T., Maia, A. C., Jr., et al. (2007). A preliminary study revealing a new association in patients undergoing maintenance hemodialysis: manganism symptoms and T1 hyperintense changes in the basal ganglia. American Journal of Neuroradiology, 28(8), 1474–1479.CrossRefPubMed

Dorman, D. C., Brenneman, K. A., McElveen, A. M., Lynch, S. E., Roberts, K. C., & Wong, B. A. (2002). Olfactory transport: a direct route of delivery of inhaled manganese phosphate to the rate brain. Journal of Toxicology and Environmental Health. Part A, 65(20), 1493–1511.CrossRefPubMed

Dörner, K., Dziadzka, S., Höhn, A., Sievers, E., Oldigs, H. D., Schulz-Lell, G., et al. (1989). Longitudinal manganese and copper balances in young infants and preterm infants fed on breastmilk and adapted cow’s milk formulas. British Journal of Nutrition, 61, 559–572.CrossRefPubMed

Edsall, D. L., Wilbur, F. P., & Drinker, C. K. (1919). The occurrence, course and prevention of chronic manganese poisoning. Journal of Industrial Hygiene, 1, 183–193.

Elder, A., Glein, R., Silva, V., Feikert, T., Opanashuk, L., Carter, J., et al. (2006). Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environmental Health Perspectives, 114(8), 1172–1178.PubMed

EPA. (2003). Health effects support document for manganese. EPA822R03003, U.S. Environmental Protection Agency, Washington DC. http://www.epa.gov/safewater/ccl/pdfs/reg_determine1/support_cc1_magnese_healtheffects.pdf. Accessed 10 July 2009.

Fell, J. M., Reynolds, A. P., Meadows, N., Khan, K., Long, S. G., Quaghebeur, G., et al. (1996). Manganese toxicity in children receiving long-term parenteral nutrition. Lancet, 347(9010), 1218–1221.CrossRefPubMed

Finkelstein, M. M., & Jerrett, M. (2007). A study of the relationships between Parkinson’s disease and markers of traffic-derived and environmental manganese air pollution in two Canadian cities. Environmental Research, 104, 420–432.CrossRefPubMed

Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J., et al. (2009). Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nature Genetics, 41, 308–315.CrossRefPubMed

Golub, M. S., Hogrefe, C. E., Germann, S. L., Tran, T. T., Beard, J. L., Crinella, F. M., et al. (2005). Neurobehavioral evaluation of rhesus monkey infants fed cow’s milk formula, soy formula, or soy formula with added manganese. Neurotoxicology and Teratology, 27(4), 615–627.CrossRefPubMed

Gorell, J. M., Johnson, C. C., Rybicki, B. A., Peterson, E. L., Kortsha, G. X., Brown, G. G., et al. (1999). Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson’s disease. Neurotoxicology, 20, 239–248.PubMed

Grandjean, P., Bellinger, D., Bergman, A., Cordier, S., Davey-Smith, G., Eskenazi, B., et al. (2007). The Faroes Statement: Human health effects of developmental exposure to chemicals in our environment. Basic & Clinical Pharmacology & Toxicology, 102(2), 73–75.

Grandjean, P., & Landrigan, P. (2006). Developmental neurotoxicity of industrial chemicals. Lancet, 368(9553), 2167–2178.CrossRefPubMed

Guilarte, T. R., & Chen, M. K. (2007). Manganese inhibits NMDA receptor channel function: Implications to psychiatric and cognitive effects. Neurotoxicology, 28(6), 1147–1152.CrossRefPubMed

Gwiazda, R., Lucchini, R., & Smith, D. (2007). Adequacy and consistency of animal studies to evaluate the neurotoxicity of chronic low-level manganese exposure in humans. Journal of Toxicology and Environmental Health. Part A, 70(7), 594–605.CrossRefPubMed

Harper, P. S. (2002). Huntington’s disease: A historical background. In G. Bates, P. S. Harper, & L. Jones (Eds.), Huntington’s disease (3rd edn., pp. 3–24). Oxford: Oxford University Press. ISBN 0-19-851060-8.

Higashi, Y., Asanuma, M., Miyazaki, I., Hattori, N., Mizuno, Y., & Ogawa, N. (2004). Parkin attenuates manganese-induced dopaminergic cell death. Journal of Neurochemistry, 89, 1490–1497.CrossRefPubMed

Huang, C. C., Chu, N. S., Lu, C. S., Chen, R. S., Schulzer, M., & Calne, D. B. (2007). The natural history of neurological manganism over 18 years. Parkinsonism & Related Disorders, 13(3), 143–145.CrossRef

IEH/IOM. (2004). Institute for Environment and Health/Institute of Occupational Medicine Occupational exposure limits: Criteria document for manganese and inorganic manganese compounds (Web Report W17), Leicester, UK, MRC Institute for Environment and Health. http://www.le.ac.uk/ieh. Accessed 10 July 2009.

IUPAC. (1993). International Union of Pure and Applied Chemistry, Clinical Chemistry Division, Commission on Toxicology, Glossary for Chemists of Terms Used in Toxicology (IUPAC Recommendations 1993). Pure and Applied Chemistry, 65(9), 2003–2122.

Jursa, T., & Smith, D. R. (2009). Ceruloplasmin alters the tissue disposition and neurotoxicity of manganese, but not its loading onto transferrin. Toxicological Sciences, 107(1), 182–193.CrossRefPubMed

Kenangil, G., Ertan, S., Sayilir, I., & Ozekmekçi, S. (2006). Progressive motor syndrome in a welder with pallidal T1 hyperintensity on MRI: A two-year follow-up. Movement Disorders, 21(12), 2197–2200.CrossRefPubMed

Kim, Y., Kim, J. W., Ito, K., Lim, H. S., Cheong, H. K., Kim, J. Y., et al. (1999a). Idiopathic Parkinsonism with superimposed manganese exposure: Utility of positron emission tomography. Neurotoxicology, 20(2–3), 249–252.PubMed

Kim, Y., Kim, K. S., Yang, J. S., Park, I. J., Kim, E., Jin, Y., et al. (1999b). Increase in signal intensities on T1-weighted magnetic resonance images in asymptomatic manganese-exposed workers. Neurotoxicology, 20(6), 901–907.PubMed

Kim, Y., Kim, J. M., Kim, J. W., Yoo, C. I., Lee, C. R., Lee, J. H., et al. (2002). Dopamine transporter density is decreased in Parkinsonian patients with a history of manganese exposure: What does it mean? Movement Disorders, 17, 568–575.CrossRefPubMed

Klos, K. J., Ahlskog, J. E., Josephs, K. A., Fealey, R. D., Cowl, C. T., & Kumar, N. (2005). Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: Probable manganese neurotoxicity. Archives of Neurology, 62(9), 1385–1390.CrossRefPubMed

Konstantinova, T. N., Lakhman, O. L., Katamanova, E. V., Kartapol’tseva, N. V., Meshcheriagin, V. A., Rusanova, D. V., et al. (2009). Clinical cases of occupational chronic manganese intoxication. Meditsina truda i promyshlennaia ekologiia, 1, 27–31 (in Russian).PubMed

Lesage, S., & Brice, A. (2009). Parkinson’s disease: From monogenic forms to genetic susceptibility factors. Human Molecular Genetics, 18, R48–R59.CrossRefPubMed

Li, G. J., Zhang, L., Lu, L., Wu, P., & Zheng, W. (2004). Occupational exposure to welding fume among welders: Alterations of manganese, iron, zinc, copper, and lead in body fluids and the oxidative stress status. Journal of Occupational and Environmental Medicine, 46, 241–248.CrossRefPubMed

Ljung, K. S., Kippler, M. J., Goessler, W., Grandér, G. M., Nermell, B. M., & Vahter, M. E. (2009). Maternal and early life exposure to manganese in rural Bangladesh. Environmental Science and Technology, 43(7), 2595–2601.CrossRefPubMed

Ljung, K., & Vahter, M. (2007). Time to re-evaluate the guideline value for manganese in drinking water? Environmental Health Perspectives, 115, 1533–1538.PubMedCrossRef

Lönnerdal, B. (1994). Manganese nutrition of infants. In D. J. Klimis-Tavantzis (Ed.), Manganese in health and disease (pp. 176–191). Boca Raton, FL: CRC Press.

Lu, L., Zhang, L. L., Li, G. J., Guo, W., Liang, W., & Zheng, W. (2005). Serum concentrations of manganese and iron as the potential biomarkers for manganese exposure in welders. Neurotoxicology, 26, 257–265.CrossRefPubMed

Lucchini, R., Albini, E., Benedetti, L., Borghesi, S., Coccaglio, R., Malara, E. C., et al. (2007a). High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. American Journal of Industrial Medicine, 50, 788–800.CrossRefPubMed

Lucchini, R., Albini, E., Benedetti, L., Zoni, S., Caruso, A., Nan, E., et al. (2007b). Neurological and neuropsychological features in Parkinsonian patients exposed to neurotoxic metals. Giornale Italiano di Medicina del Lavoro ed Ergonomia, 29, 280–281.PubMed

Lucchini, R., Bergamaschi, E., Smargiassi, A., Festa, D., & Apostoli, P. (1997). Motor function, olfactory threshold, and hematological indices in manganese-exposed ferroalloy workers. Environmental Research, 73(1–2), 175–180.CrossRefPubMed

Lucchini, R., Squitti, R., Albini, E., Benedetti, L., Borghesi, S., Nan, E., et al. (2008). Manganese exposure as a determinant of Parkinsonian damage. Cell Biology and Toxicology, 24, 423–470.CrossRef

Lucchini, R., & Zimmerman, N. (2009). Lifetime cumulative exposure as a threat for neurodegeneration: Need for prevention strategies on a global scale. Neurotoxicology. doi:10.1016/j.neuro.2009.10.003.

Martin, C. (2006). Manganese neurotoxicity: Connecting the dots along the continuum of dysfunction. Neurotoxicology, 27, 347–349.CrossRefPubMed

Meco, G., Bonifati, V., Vanacore, N., & Fabrizio, E. (1994). Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate). Scandinavian Journal of Work, Environment and Health, 20(4), 301–305.PubMed

Nelson, K., Golnick, J., Korn, T., & Angle, C. (1993). Manganese encephalopathy: utility of early magnetic resonance imaging. British Journal of Industrial Medicine, 50(6), 510–513.PubMed

Newland, M. C., & Weiss, B. (1992). Persistent effects of manganese on effortful responding and their relationship to manganese accumulation in the primate globus pallidus. Toxicology and Applied Pharmacology, 113, 87–97.CrossRefPubMed

Øygard, K., Riise, T., Moen, B., & Engelsen, B. A. (1992). Occurrence of Parkinson’s disease (PD) and Parkinsonism (P) in Sauda community. Proceedings of the symposium on manganese toxicity (pp. 179–182). International Manganese Institute, Paris, France.

Park, J. D., Chung, Y. H., Kim, C. Y., Ha, C. S., Yang, S. O., Khang, H. S., et al. (2007). Comparison of high MRI T1 signals with manganese concentration in brains of cynomolgus monkeys after 8 months of stainless steel welding-fume exposure. Inhalation Toxicology, 19, 965–971.CrossRefPubMed

Parkinson, J. (2002). Neuropsychiatric classics: James Parkinson: an essay on the shaking palsy. Journal of Neuropsychiatry and Clinical Neurosciences, 14, 223–236.PubMed

Perl, D. P., & Olanow, C. W. (2007). The neuropathology of manganese-induced Parkinsonism. Journal of Neuropathology and Experimental Neurology, 66(8), 675–682.CrossRefPubMed

Ponsen, M. M., Stoffers, D., Twisk, J. W., Wolters, E. Ch., & Berendse, H. W. (2009). Hyposmia and executive dysfunction as predictors of future Parkinson’s disease: A prospective study. Movement Disorders, 24(7), 1060–1065.CrossRefPubMed

Pratesi, A., Vella, A., Pasini, E., Salvi, F., & Mascalchi, M. (2008). Parkinsonism in polycythaemia vera probably due to manganism. Movement Disorders, 23(16), 2420–2421.CrossRefPubMed

Racette, B. A., McGee-Minnich, L., Moerlein, S. M., Mink, J. W., Videen, T. O., & Perlmutter, J. S. (2001). Welding-related Parkinsonism: Clinical features, treatment, and pathophysiology. Neurology, 56, 8–13.PubMed

Racette, B. A., Tabbal, S. D., Jennings, D., Good, L., Perlmutter, J. S., & Evanoff, B. (2005). Prevalence of Parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology, 64(2), 230–235.PubMed

Ritz, B. R., Manthripragada, A. D., Costello, S., Lincoln, S. J., Farrer, M. J., Cockburn, M., et al. (2009). Dopamine transporter genetic variants and pesticides in Parkinson’s disease. Environmental Health Perspectives, 117(6), 964–969.PubMed

Rodier, J. (1955). Manganese poisoning in Moroccan miners. British Journal of Industrial Medicine, 12.

Roth, J. A. (2006). Homeostatic and toxic mechanisms regulating manganese uptake, retention, and elimination. Biological Research, 39, 45–57.CrossRefPubMed

Roth, J. A. (this issue). Are there common biochemical and molecular mechanisms controlling manganism and Parkinsonism? Neuromolecular Medicine. doi:10.1007/s12017-009-8088-8.

Roth, J. A., & Garrick, M. D. (2003). Iron interactions and other biological reactions medicating the physiological and toxic actions of manganese. Biochemical Pharmacology, 66, 1–13.CrossRefPubMed

Rovira, A., Alonso, J., & Córdoba, J. (2008). MR imaging findings in hepatic encephalopathy. American Journal of Neuroradiology, 29(9), 1612–1621.CrossRefPubMed

Sadek, A. H., Rauch, R., & Schulz, P. E. (2003). Parkinsonism due to manganism in a welder. International Journal of Toxicology, 22, 393–401.PubMed

Schaumburg, H. H., Herskovitz, S., & Cassano, V. A. (2006). Occupational manganese neurotoxicity provoked by hepatitis C. Neurology, 67(2), 322–323.CrossRefPubMed

Schuler, P., Oyanguren, H., Maturana, V., Valenzuela, A., Cruz, E., Plaza, V., et al. (1957). Manganese poisoning: Environmental and medical study at a Chilean mine. Industrial Medicine and Surgery, 26, 167–173.PubMed

Shinotoh, H., Snow, B. J., Hewitt, K. A., Pate, B. D., Doudet, D., Nugent, R., et al. (1995). MRI and PET studies of manganese-intoxicated monkeys. Neurology, 45(6), 1199–1204.PubMed

Smith, D., Gwiazda, R., Bowler, R., Roels, H., Park, R., Taicher, C., et al. (2007). Biomarkers of manganese exposure in humans. American Journal of Industrial Medicine, 50(11), 801–811.CrossRefPubMed

Smyth, L. T., Ruhf, R. C., Whitman, N. E., & Dugan, T. (1973). Clinical manganism and exposure to manganese in the production and processing of ferromanganese alloy. Journal of Occupational Medicine, 15(2), 101–109.PubMed

Squitti, R., Gorgone, G., Panetta, V., Lucchini, R., Bucossi, S., Albini, E., et al. (2009). Implications of metal exposure and liver function in Parkinsonian patients resident in the vicinities of ferroalloy plants. Journal of Neural Transmission, 116(10), 1281–1287.CrossRefPubMed

Stampfer, M. J. (2009). Welding occupations and mortality from Parkinson’s disease and other neurodegenerative diseases among United States men, 1985–1999. Journal of Occupational and Environmental Hygiene, 6(5), 267–272.CrossRefPubMed

Stepens, A., Logina, I., Liguts, V., Aldins, P., Eksteina, I., Platkājis, A., et al. (2008). A Parkinsonian syndrome in methcathinone users and the role of manganese. New England Journal of Medicine, 358(10), 1009–1017.CrossRefPubMed

Thompson, K., Molina, R. M., Donaghey, T., Schwob, J. E., Brain, J. D., & Wessling-Resnick, M. (2007). Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB Journal, 21(1), 223–230.CrossRefPubMed

Verity, M. A. (1999). Manganese neurotoxicity: A mechanistic hypothesis. Neurotoxicology, 20, 489–497.PubMed

Verschoor, L., & Verschoor, A. H. (2009). Work-related disease. Nederlands tijdschrift voor geneeskunde, 153(20), 964–967 (in Dutch).PubMed

Von Campenhausen, S., Bornschein, B., Wick, R., Botzel, K., Sampaio, C., Poewe, W., et al. (2005). Prevalence and High Prevalence of Parkinsonian Disorders incidence of Parkinson’s disease in Europe. Prevalence and high prevalence of Parkinsonian disorders incidence of Parkinson’s disease in Europe, 15, 473–490.CrossRef

Von Jaksch, R. (1909). Ueber gehaufte diffuse Erkrankun- gen des Gehirns und Ruckenmarks, an den Typus der multiplen Sklerose mahnend, welche durch eine besondere Aetiologie gekennzeichnet sind. Klein Rundsch, 15, 729–733 (in German).

Wang, J. D., Huang, C. C., Hwang, Y. H., Chiang, J. R., Lin, J. M., & Chen, J. S. (1989). Manganese induced Parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. British Journal of Industrial Medicine, 46, 856–859.PubMed

Wasserman, G. A., Liu, X., Parvez, F., Ahsan, H., Levy, D., Factor-Litvak, P., et al. (2006). Water manganese exposure and children’s intellectual function in Araihazar, Bangladesh. Environmental Health Perspectives, 114, 124–129.PubMed

Weiss, B. (2006). Economic implications of manganese neurotoxicity. Neurotoxicology, 27(3), 362–368.CrossRefPubMed

Wexler, A. (2008). The woman who walked Into the sea. Huntington’s and the making of a genetic disease (pp. 288). Yale University Press. ISBN 9780300105025.

WHO. (1981). Manganese. Environmental health criteria 17. Geneva, Switzerland: World Health Organization.

WHO. (2004). Manganese in drinking-water. Background document for development of WHO guidelines for drinking-water quality. World Health Organization. WHO/SDE/WSH/03.04/104. http://www.who.int/water_sanitation_health/dwq/chemicals/manganese.pdf. Accessed 10 July 2009.

Wright, R. O., Amarasiriwardena, C., Woolf, A. D., Jim, R., & Bellinger, D. C. (2006). Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology, 27(2), 210–216.CrossRefPubMed

Wright, A. K., & Arbuthnott, G. W. (2007). The influence of the subthalamic nucleus upon the damage to the dopamine system following lesions of globus pallidus in rats. European Journal of Neuroscience, 26(3), 642–648.CrossRefPubMed

Yamada, M., Ohno, S., Okayasu, I., Okeda, R., Hatakeyama, S., Watanabe, H., et al. (1986). Chronic manganese poisoning: A neuropathological study with determination of manganese distribution in the brain. Acta Neuropathologica, 70(3–4), 273–278.CrossRefPubMed

Yokel, R. A. (this issue). Manganese flux across the blood–brain barrier. Neuromolecular Medicine. doi:10.1007/s12017-009-8101-2.

Zota, A. R., Ettinger, A. S., Bouchard, M., Amarasiriwardena, C. J., Schwartz, J., Hu, H., et al. (2009). Maternal blood manganese levels and infant birth weight. Epidemiology, 20(3), 367–373.CrossRefPubMed

Titel: From Manganism to Manganese-Induced Parkinsonism: A Conceptual Model Based on the Evolution of Exposure
verfasst von: Roberto G. Lucchini
Christopher J. Martin
Brent C. Doney
Publikationsdatum: 01.12.2009
Verlag: Humana Press Inc
Erschienen in: NeuroMolecular Medicine / Ausgabe 4/2009
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-009-8108-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2009

Manganese Flux Across the Blood–Brain Barrier

Modelling Parkinson’s Disease in Drosophila

Exercise and Bipolar Disorder: A Review of Neurobiological Mediators

Metal Ion Physiopathology in Neurodegenerative Disorders

Manganese and its Role in Parkinson’s Disease: From Transport to Neuropathology

Interleukin-1 Beta −511C/T Genetic Polymorphism is Associated with Age of Onset of Geriatric Depression